Last reviewed · How we verify
NCT03967106: MSIPC-2
RIPC on Activity, Fatigue and Gait in MS
NA trial testing Ischaemic Preconditioning in Multiple Sclerosis in 92 participants. Completed in 31 March 2023.
31 March 2023
Quick facts
| Lead sponsor | Sheffield Teaching Hospitals NHS Foundation Trust |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 92 |
| Start date | 19 August 2019 |
| Primary completion | 31 March 2023 |
| Estimated completion | 31 March 2023 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Ischaemic Preconditioning
- Sham
Conditions studied
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Who can join
18 and older, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates whether Remote Ischaemic Preconditioning (RIPC) can improve activity, gait and fatigue in people with Multiple Sclerosis. Half the participants will receive RIPC, the other half will receive a sham treatment.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Mobility recorded by wearable devices and gold standards: the Mobilise-D procedure for data standardization.
Palmerini L, Reggi L, Bonci T, Del Din S, et al · · 2023 · cited 25× · PMID 36658136 · DOI 10.1038/s41597-023-01930-9 -
Remote ischaemic conditioning for neurological disorders-a systematic review and narrative synthesis.
Alhashimi A, Kamarova M, Baig SS, Nair KPS, et al · · 2024 · cited 5× · PMID 39702489 · DOI 10.1186/s13643-024-02725-8 -
Variability of Multiple Sclerosis Walking Scale and Multiple Sclerosis Impact Scale Scores in People Without Multiple Sclerosis.
Binshalan T, Buckley E, Nair S, Mcneill A. · · 2024 · cited 1× · PMID 38322083 · DOI 10.7759/cureus.51811 -
Abstracts of the BSPRM Annual Scientific Conference 2024
· 2025 -
Remote Ischaemic Conditioning for Neurological Disorders – A Systematic Review and Narrative Synthesis
Alhashimi A, Kamarova M, B S, Nair KS, et al · · 2024 · DOI 10.21203/rs.3.rs-3974093/v1
Verify or expand the search:
- PubMed search for NCT03967106
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ischaemic Preconditioning
Trials testing the same drug.
- NCT05954715 — Ischaemic Preconditioning and Upper Body Exercise Performance in Persons With Spinal Cord Injury · NA · unknown
Other recruiting trials for Multiple Sclerosis
Currently open trials in the same condition.
- NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other Sheffield Teaching Hospitals NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07407712 — Better Outcomes Through Optimal Sleep in Surgical Training · NA · recruiting
- NCT07172555 — Virtual Dietetic Interventions in Patients With Coeliac · NA · recruiting
- NCT06310993 — Exercise to Boost Immunity in Advanced Cancer · NA · not yet recruiting
- NCT06905405 — The Use of Advanced Imaging in HFpEF · recruiting
- NCT06633627 — Neurological Responses in Patients with Dentine Hypersensitivity · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03967106 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sheffield Teaching Hospitals NHS Foundation Trust
- Last refreshed: 5 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03967106.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing